drug
APL-1501
Preclinicalupdated 3mo agoby Asieris Pharmaceuticals (USA) Inc
Preclinicalcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying APL-1501
- phase1A Study of APL-1501 Extended Release Capsules Compared to APL-1202 Immediate Release Tablets in Healthy Volunteers
- phase1A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that